• Home
• People
  • Management
  • Scientific Advisors
  • Clinical Advisors
• Technology
• About CD40 ligand
• Clinical Products
  • Clinical Pipeline
  • HBV Therapeutic Vaccine
  • Tumor Immunotherapy
  • Ovarian Cancer Immunotherapy
  • CD40-B Cell Immunotherapy
  • Precision Immunization™
• Laboratory Products
• Publications
• News
• Intellectual Property
• About MultimericBio
  • Company
  • Investors
• Contact

Investors

 

Multimeric Biotherapeutics, Inc. is currently funded by its founders, Angel investors, and NIH grants. It is seeking additional Angel investors and first round funding.

Interested investors are invited to contact: info{at}multimericbio.com